May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
Clinical application of optoacoustic on–line dosimetry in Selective–RPE–Laser–Treatment (SRT)
Author Affiliations & Notes
  • E. Porksen
    Dept of Ophthalmology, UKSH Campus, Luebeck, Germany
  • H. Elsner
    Dept of Ophthalmology, UKSH Campus, Luebeck, Germany
  • D. Theisen–Kunde
    Med Laser Ctr Luebeck, Luebeck, Germany
  • R. Brinkmann
    Med Laser Ctr Luebeck, Luebeck, Germany
  • C. Klatt
    Dept of Ophthalmology, UKSH Campus, Kiel, Germany
  • A. Bunse
    Dept of Ophthalmology, UKSH Campus, Kiel, Germany
  • P. Hamilton
    St. Thomas Hosp London, London, United Kingdom
  • R. Birngruber
    Med Laser Ctr Luebeck, Luebeck, Germany
  • H. Laqua
    Dept of Ophthalmology, UKSH Campus, Luebeck, Germany
  • J. Roider
    Dept of Ophthalmology, UKSH Campus, Kiel, Germany
  • Footnotes
    Commercial Relationships  E. Porksen, None; H. Elsner, None; D. Theisen–Kunde, None; R. Brinkmann, None; C. Klatt, None; A. Bunse, None; P. Hamilton, None; R. Birngruber, None; H. Laqua, None; J. Roider, None.
  • Footnotes
    Support  none
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 4074. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      E. Porksen, H. Elsner, D. Theisen–Kunde, R. Brinkmann, C. Klatt, A. Bunse, P. Hamilton, R. Birngruber, H. Laqua, J. Roider; Clinical application of optoacoustic on–line dosimetry in Selective–RPE–Laser–Treatment (SRT) . Invest. Ophthalmol. Vis. Sci. 2004;45(13):4074.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Selective–RPE–laser–treatment (SRT) is currently investigated in a multicenter clinical trial for patients with diabetic maculopathy (DMP). In comparison to conventional argon laser treatment SRT uses a train of µs laser pulses. Due to intracellular microbubble formation around the strongly absorbing melanosomes the irradiated RPE cells are selectively damaged sparing retinal structures. The RPE lesions are biomicroscopically invisible and therefore conventional dosimetry of laser energy is impossible. In this study optoacoustic value (OA) measurements recorded during SRT are evaluated in order to establish a reliable on–line dosimetry means. Methods: 17 patients with focal DMP have been treated in Luebeck with SRT using a frequency doubled Q–switched Nd:YLF laser (527 nm) by applying a train of 30 pulses, each 1,7 µs, at a repetition rate of 100 Hz. Prior of treating the central pathology test expositions are placed close to the vascular arcades using defined energy levels (100–400 µJ). For each SRT exposition an OA value is recorded by a modified contact glass with an integrated microphone. 1 hour post SRT Fluorescein (FLA) and Indocyanin Green (ICG) angiography is performed to visualize RPE lesions caused by SRT expositions. OA values and angiography results are correlated to determine an OA value threshold causing visible SRT lesions on ICG. Results: ICG delineated much more precisely RPE lesions caused by SRT expositions than FLA does. The recorded OA values showed a range between 0,10 and 4,00. At an OA value of 0,3 we have been able to determine a threshold for the used contact glas. At laser energy levels producing OA values of 0,3 and above we have seen visible RPE lesions on ICG in > 96%. At energy levels producing OA–values below 0,3 we have seen visible RPE lesions on ICG in < 21%. Conclusions:Having determined the OA–value threshold for the used contact glas, optoacoustics on–line dosimetry is a reliable means in order to perform save and efficient SRT.

Keywords: laser • retinal pigment epithelium • clinical (human) or epidemiologic studies: treatment/prevention assessment/controlled clinical trials 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×